These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Issues in the pharmacological treatment of obsessive-compulsive disorder. Math SB; Janardhan Reddy YC Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795 [TBL] [Abstract][Full Text] [Related]
5. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom. Albert U; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184 [TBL] [Abstract][Full Text] [Related]
7. Clinical features associated to refractory obsessive-compulsive disorder. Ferrão YA; Shavitt RG; Bedin NR; de Mathis ME; Carlos Lopes A; Fontenelle LF; Torres AR; Miguel EC J Affect Disord; 2006 Aug; 94(1-3):199-209. PubMed ID: 16764938 [TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy. Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206 [TBL] [Abstract][Full Text] [Related]
14. [Obsessive-compulsive disorder in children and adolescents]. Jans T; Walitza S; Warnke A Prax Kinderpsychol Kinderpsychiatr; 2008; 57(6):429-56. PubMed ID: 18800672 [TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. Shetti CN; Reddy YC; Kandavel T; Kashyap K; Singisetti S; Hiremath AS; Siddequehusen MU; Raghunandanan S J Clin Psychiatry; 2005 Dec; 66(12):1517-23. PubMed ID: 16401151 [TBL] [Abstract][Full Text] [Related]
16. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap. Szechtman H; Harvey BH; Woody EZ; Hoffman KL Pharmacol Rev; 2020 Jan; 72(1):80-151. PubMed ID: 31826934 [TBL] [Abstract][Full Text] [Related]
17. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912 [TBL] [Abstract][Full Text] [Related]
18. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder. Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937 [TBL] [Abstract][Full Text] [Related]
19. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Ivarsson T; Skarphedinsson G; Kornør H; Axelsdottir B; Biedilæ S; Heyman I; Asbahr F; Thomsen PH; Fineberg N; March J; Psychiatry Res; 2015 May; 227(1):93-103. PubMed ID: 25769521 [TBL] [Abstract][Full Text] [Related]